Resultado de búsqueda
Evidence-Based Guidelines. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline from AAN, AES, and SMFM (May 2024) Practice Guideline Update Summary: Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New-onset Epilepsy
- Guideline for Treatment of Prolonged Seizures in Children and Adults
American Epilepsy Society issues guideline and treatment...
- Get Involved
AES members gather at the Annual Meeting each December, but...
- Privacy Policy
For Non-Epilepsy Specialists; For Fellows; Epilepsy and...
- Guideline for Treatment of Prolonged Seizures in Children and Adults
Home. Guidelines. Print Share. Guidelines. Access current reports, guidelines and more. Definition & Classification. Definition of Epilepsy (2014) and other classification documents. Guidelines & Reports. Current practice guidelines, reports, and position papers. EpilepsyDiagnosis.org. Cutting-edge online diagnostic manual of the epilepsies.
12 de may. de 2021 · The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.
14 de jul. de 2021 · Guidelines. In 2015, the American Academy of Neurology and the American Epilepsy Society provided joint guidelines on the management of unprovoked first seizure in adults. 2 The 2012...
- Phil E.M. Smith
- 2021
13 de dic. de 2022 · Society guideline links: Seizures and epilepsy in adults; Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis; Suicidal ideation and behavior in adults; Surgical treatment of epilepsy in adults; Treatment of vitamin B12 and folate deficiencies
Original Research. ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes.
American Epilepsy Society Guidelines. PGB was significantly superior to placebo at daily doses of 150 mg, 300 mg, and 600 mg, with >50% responder rates and greater median percent seizure reduction, in a dose-related manner.